Name: Return on Assets (ROA)

Definition: ROA shows how efficiently the company turns everything it owns — its entire asset base — into net profit after all costs and taxes. A higher ROA means the business squeezes more profit from its assets. Lower ROA might reflect poor asset utilization or heavy reliance on expensive financing.

Interpretation:
• In '2021', SRPT's return on assets was -13.3%, representing returns generated from total assets. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at -56.5%.
• In '2022', SRPT's return on assets was -22.4%, representing returns generated from total assets. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at -58.4%. Industry average declined by 2.0% from previous year.
• In '2023', SRPT's return on assets was -16.8%, representing returns generated from total assets. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at -66.2%. Industry average declined by 7.8% from previous year.
• In '2024', SRPT's return on assets was 6.5%, representing returns generated from total assets. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at -65.9%. Industry average increased by 0.3% compared to previous year.
Overall, SRPT's return on assets has been volatile but showed an upward trend over the past 4 years.

Formula: ROA = Net Income / Total Assets

Good Range: Commonly 5%-15%.